Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,210
Total Claims
$4.3M
Drug Cost
239
Beneficiaries
$18K
Cost/Patient
Risk Score Breakdown 44/100
Score components are additive. Read full methodology
Peer Comparison vs. 775 Hematology providers
+997%
Opioid rate vs peers
55.9% vs 5.1% avg
+1%
Cost per patient vs peers
$18K vs $18K avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Opioid Prescribing
55.9%
Opioid Rate
2,354
Opioid Claims
$67K
Opioid Cost
33.9%
Long-Acting Rate
This provider's opioid prescribing rate of 55.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 3,127 claims · $262K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Ibrutinib | 59 | $926K |
| Lenalidomide | 46 | $875K |
| Eltrombopag Olamine | 38 | $640K |
| Avatrombopag Maleate | 21 | $350K |
| Deferasirox | 12 | $300K |
| Voxelotor | 27 | $247K |
| Thalidomide | 11 | $115K |
| Rivaroxaban | 120 | $90K |
| Apixaban | 122 | $88K |
| Peginterferon Alfa-2a | 12 | $54K |
| Deferasirox | 80 | $53K |
| Oxycodone Hcl | 20 | $22K |
| Morphine Sulfate | 448 | $12K |
| Hydroxyurea | 153 | $8,405 |
| Morphine Sulfate | 384 | $8,264 |
Prescribing Profile
Patient Profile
54
Avg Age
58%
Female
3.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About